Table 1.
Clinical and biochemical characteristics of the male subjects
| TG/HDL-C quartiles in males | |||||
|---|---|---|---|---|---|
|
| |||||
| Q1 (< 0.77) (n = 239) | Q2 (0.77-1.18) (n = 224) | Q3 (1.19-1.86) (n = 231) | Q4 (> 1.86) (n = 232) | P-value | |
| Age (years) | 41 (37-48) | 41 (37-50) | 40 (36-48) | 42 (38-49) | 0.145 |
| BMI (kg/m2) | 22.3 ± 2.9 | 24.1 ± 3.1 | 24.9 ± 3.2 | 25.9 ± 2.9 | 0.001 |
| Systolic BP (mmHg) | 115.3 ± 9.2 | 117.3 ± 9.6 | 118.5 ± 9.6 | 118.9 ± 9.2 | 0.001 |
| Diastolic BP (mmHg) | 69.9 ± 7.7 | 72.1 ± 8.3 | 73.6 ± 8.1 | 73.9 ± 7.6 | 0.001 |
| Fasting glucose (mmol/l) | 5.17 ± 0.43 | 5.24 ± 0.48 | 5.18 ± 0.45 | 5.32 ± 0.52 | 0.005 |
| Total cholesterol (mmol/l) | 5.32 ± 0.92 | 5.37 ± 0.97 | 5.52 ± 1.06 | 5.62 ± 1.04 | 0.008 |
| LDL-C (mmol/l) | 3.09 ± 0.75 | 3.26 ± 0.80 | 3.39 ± 0.81 | 3.18 ± 0.88 | 0.001 |
| HDL-C (mmol/l) | 1.57 (1.32-1.81) | 1.33 (1.14-1.53) | 1.15 (1.04-1.34) | 1.05 (0.95-1.19) | 0.001 |
| Triglycerides (mmol/l) | 0.84 (0.68-1.00) | 1.27 (1.10-1.46) | 1.77 (1.50-2.03) | 2.77 (2.30-3.64) | 0.001 |
| Uric acid (mg/dl) | 374.3 ± 75.1 | 391.5 ± 81.2 | 419.7 ± 80.5 | 433.4 ± 89.6 | 0.001 |
| eGFR | 83.9 ± 17.1 | 88.6 ± 16.7 | 92.3 ± 20.0 | 94.1 ± 19.9 | 0.001 |
| Mean ABI | 1.11 ± 0.07 | 1.13 ± 0.07 | 1.12 ± 0.06 | 1.12 ± 0.07 | 0.102 |
| High baPWV (%) | 18.8% | 23.4% | 28.4% | 31.9% | 0.007 |
BMI, Body mass index; BP, blood pressure; LDL-C, LDL cholesterol; HDL-C, HDL cholesterol; eGFR, estimated glomerular filtration rate; ABI, ankle-brachial index; baPWV, brachial-ankle pulse wave velocity.